[Federal Register Volume 77, Number 98 (Monday, May 21, 2012)]
[Notices]
[Page 30015]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12279]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announce the following meeting of the aforementioned 
committee:

    Times and Dates: 8:00 a.m.-5:00 p.m., June 20, 2012, 8:00 a.m.-
1:00 p.m., June 21, 2012.
    Place: CDC, Tom Harkin Global Communications Center, 1600 
Clifton Road NE., Building 19, Kent ``Oz'' Nelson Auditorium, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines. Further, under provisions of the Affordable Care Act, 
at section 2713 of the Public Health Service Act, immunization 
recommendations of the ACIP that have been adopted by the Director 
of the Centers for Disease Control and Prevention must be covered by 
applicable health plans.
    Matters To Be Discussed: The agenda will include discussions on: 
adult immunization, human papillomavirus vaccines, hepatitis B 
vaccine, meningococcal vaccines, influenza, pneumococcal vaccines, 
measles-mumps-rubella vaccine, pertussis, development of evidence-
based recommendations, Institute of Medicine vaccine committee 
report, and anthrax vaccine adsorbed and vaccine supply. 
Recommendation votes are scheduled for pneumococcal vaccines and for 
influenza. Time will be available for public comment.
    Agenda items are subject to change as priorities dictate.
    Meeting is webcast live via the World Wide Web; for instructions 
and more information on ACIP please visit the ACIP Web site: http://www.cdc.gov/vaccines/recs/acip/.
    Contact Person for More Information: Stephanie B. Thomas, 
National Center for Immunization and Respiratory Diseases, CDC, 1600 
Clifton Road NE., MS-A27, Atlanta, Georgia 30333, Telephone (404) 
639-8836; Email ACIP@CDC.GOV.

    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

    Dated: May 15, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2012-12279 Filed 5-18-12; 8:45 am]
BILLING CODE 4160-18-P